• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在新冠疫情期间对湿性年龄相关性黄斑变性服务进行重组,以实现社交距离门诊诊所(SDOC)。

Restructuring Wet Age-Related Macular Degeneration Services During the COVID-19 Pandemic to Allow Social Distancing Outpatient Clinics (SDOC).

作者信息

Groppe Markus, Bindra Mandeep Singh

机构信息

Retina Unit, Buckinghamshire Healthcare NHS Trust, Stoke Mandeville and Amersham Hospital, Aylesbury, HP21 8AL, UK.

出版信息

Clin Ophthalmol. 2021 Feb 17;15:651-659. doi: 10.2147/OPTH.S269596. eCollection 2021.

DOI:10.2147/OPTH.S269596
PMID:33628008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7898216/
Abstract

BACKGROUND

COVID-19 has had a major impact on health-care provision. Social distancing will impact the organization of outpatient clinics (OCs) and require general restructuring of health care.

METHODS

Our retinal team participated in a structured fact-finding session to implement social distancing of patients and staff in wet age-related macular degeneration (wAMD) clinics. Clinic flow and performance were continually reviewed and improved. A retrospective audit of all wAMD follow-up appointments was conducted for 4 weeks from the start of the UK lockdown. A search for clinical guidance regarding retinal services was performed on the homepages of international professional bodies. The guidelines were compared to the implemented changes in our wAMD social distancing OCs (SDOCs) and potential risk examined.

RESULTS

The changes in clinic setup to achieve SDOCs are described. The average total time spent in the clinic area by each patient has reduced by 27%. The audit concluded that 65% of patients needed a treatment interval of 4-7 weeks after their appointment, 17% at either 8 or 9 weeks, and 18% at 10 weeks or beyond. The UK, Australian-New Zealand, US, and German professional ophthalmology bodies have published divergent guidelines, but all recommended a continuation of anti-VEGF injections.

CONCLUSION

Health-care provision will change and hospitals and outpatient facilities will have to adapt to the COVID-19 epidemic. We describe a clinic setup (SDOCs) that minimizes risk to patients and staff, while maintaining the ability to treat each patient and their disease individually.

摘要

背景

新型冠状病毒肺炎(COVID-19)对医疗服务产生了重大影响。社交距离措施将影响门诊诊所(OCs)的组织架构,并要求对医疗保健进行全面重组。

方法

我们的视网膜团队参与了一次结构化的实情调查会议,以在湿性年龄相关性黄斑变性(wAMD)诊所中实施患者和工作人员的社交距离措施。持续审查并改进了诊所流程和绩效。从英国封锁开始后的4周内,对所有wAMD随访预约进行了回顾性审计。在国际专业机构的主页上搜索了有关视网膜服务的临床指南。将这些指南与我们的wAMD社交距离门诊诊所(SDOCs)中实施的变更进行比较,并检查潜在风险。

结果

描述了为实现社交距离门诊诊所而对诊所设置所做的更改。每位患者在诊所区域花费的平均总时间减少了27%。审计得出结论,65%的患者在预约后需要4至7周的治疗间隔,17%的患者需要8或9周,18%的患者需要10周或更长时间。英国、澳大利亚-新西兰、美国和德国的专业眼科机构发布了不同的指南,但都建议继续进行抗血管内皮生长因子(VEGF)注射。

结论

医疗服务将发生变化,医院和门诊设施将不得不适应COVID-19疫情。我们描述了一种诊所设置(社交距离门诊诊所),该设置可将患者和工作人员的风险降至最低,同时保持对每位患者及其疾病进行个体化治疗的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b41/7898216/48c40cbd974c/OPTH-15-651-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b41/7898216/fabcd7292718/OPTH-15-651-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b41/7898216/87153147d1d1/OPTH-15-651-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b41/7898216/48c40cbd974c/OPTH-15-651-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b41/7898216/fabcd7292718/OPTH-15-651-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b41/7898216/87153147d1d1/OPTH-15-651-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b41/7898216/48c40cbd974c/OPTH-15-651-g0003.jpg

相似文献

1
Restructuring Wet Age-Related Macular Degeneration Services During the COVID-19 Pandemic to Allow Social Distancing Outpatient Clinics (SDOC).在新冠疫情期间对湿性年龄相关性黄斑变性服务进行重组,以实现社交距离门诊诊所(SDOC)。
Clin Ophthalmol. 2021 Feb 17;15:651-659. doi: 10.2147/OPTH.S269596. eCollection 2021.
2
The Effect of Treatment Discontinuation During the COVID-19 Pandemic on Visual Acuity in Exudative Neovascular Age-Related Macular Degeneration: 1-Year Results.COVID-19大流行期间治疗中断对渗出性年龄相关性黄斑变性患者视力的影响:1年结果
Ophthalmol Ther. 2021 Dec;10(4):935-945. doi: 10.1007/s40123-021-00381-y. Epub 2021 Aug 9.
3
Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.致编辑的信:COVID-19 大流行对精神分裂症患者的影响。
4
Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.致编辑的信:COVID-19 大流行对精神分裂症患者的影响。
Turk Psikiyatri Derg. 2021 Fall;32(3):219-221. doi: 10.5080/u26175.
5
Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19.黄斑服务评估和评估 COVID-19 背景下抗 VEGF 治疗的优先事项。
Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2639-2645. doi: 10.1007/s00417-020-04849-8. Epub 2020 Jul 25.
6
Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey.湿性年龄相关性黄斑变性(wAMD)治疗的当前障碍:wAMD患者及照料者调查结果
Clin Ophthalmol. 2015 Dec 1;9:2243-50. doi: 10.2147/OPTH.S92548. eCollection 2015.
7
[Retrospective investigation of anti-VEGF treatment reality and effectiveness in patients with neovascular age-related macular degeneration (AMD) in Germany: treatment reality of ranibizumab for neovascular AMD in Germany].德国新生血管性年龄相关性黄斑变性(AMD)患者抗VEGF治疗现状及疗效的回顾性调查:德国雷珠单抗治疗新生血管性AMD的治疗现状
Ophthalmologe. 2015 Mar;112(3):246-54. doi: 10.1007/s00347-014-3217-7.
8
The Burden of Macular Diseases in Central and Eastern Europe-Implications for Healthcare Systems.中东欧黄斑疾病负担及其对医疗保健系统的影响
Value Health Reg Issues. 2019 Sep;19:1-6. doi: 10.1016/j.vhri.2018.11.002. Epub 2019 Jan 8.
9
Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations.在新冠疫情期间玻璃体内注射是否必不可少?全球最佳实践模式及实用建议。
Int J Retina Vitreous. 2022 Jun 7;8(1):33. doi: 10.1186/s40942-022-00380-6.
10
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.抗血管内皮生长因子眼内注射在 COVID-19 时代:应对不同级别的疫情压力。
Graefes Arch Clin Exp Ophthalmol. 2021 Mar;259(3):567-574. doi: 10.1007/s00417-021-05097-0. Epub 2021 Feb 2.

引用本文的文献

1
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study - Fifty-Two-Week Outcomes.布罗鲁单抗治疗新生血管性年龄相关性黄斑变性——印度真实世界经验:BRAILLE研究——52周结果
Clin Ophthalmol. 2022 Dec 23;16:4303-4313. doi: 10.2147/OPTH.S395577. eCollection 2022.
2
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.新生血管性年龄相关性黄斑变性患者管理格局的变化:临床实践中的 brolucizumab。
Eye (Lond). 2022 Sep;36(9):1725-1734. doi: 10.1038/s41433-022-02008-3. Epub 2022 Mar 21.

本文引用的文献

1
Hospital visiting policies in the time of coronavirus disease 2019: A nationwide website survey in Taiwan.2019 年冠状病毒病期间的医院探视政策:台湾的全国性网站调查。
J Chin Med Assoc. 2020 Jun;83(6):566-570. doi: 10.1097/JCMA.0000000000000326.
2
The COVID-19 pandemic will redefine the future delivery of glaucoma care.新冠疫情将重新定义青光眼护理的未来交付模式。
Eye (Lond). 2020 Jul;34(7):1203-1205. doi: 10.1038/s41433-020-0958-1. Epub 2020 May 13.
3
Oculoplastic video-based telemedicine consultations: Covid-19 and beyond.基于视频的眼整形远程医疗会诊:新冠疫情及以后。
Eye (Lond). 2020 Jul;34(7):1193-1195. doi: 10.1038/s41433-020-0953-6. Epub 2020 May 12.
4
Ophthalmology Practice During the Coronavirus Disease 2019 Pandemic: The University of Pittsburgh Experience in Promoting Clinic Safety and Embracing Video Visits.2019年冠状病毒病大流行期间的眼科实践:匹兹堡大学在促进诊所安全和采用视频问诊方面的经验
Ophthalmol Ther. 2020 Sep;9(3):1-9. doi: 10.1007/s40123-020-00255-9. Epub 2020 May 6.
5
Virtual Ophthalmology: Telemedicine in a COVID-19 Era.虚拟眼科:新冠疫情时代的远程医疗。
Am J Ophthalmol. 2020 Aug;216:237-242. doi: 10.1016/j.ajo.2020.04.029. Epub 2020 Apr 30.
6
Increased risk of ocular injury seen during lockdown due to COVID-19.因新冠疫情封锁期间眼部受伤风险增加。
Cont Lens Anterior Eye. 2020 Jun;43(3):216. doi: 10.1016/j.clae.2020.04.007. Epub 2020 Apr 27.
7
Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients.COVID-19患者的眼部表现及结膜SARS-CoV-2感染比例
Ophthalmology. 2020 Jul;127(7):982-983. doi: 10.1016/j.ophtha.2020.04.028. Epub 2020 Apr 21.
8
Symptomatic COVID-19 in Eye Professionals in Wuhan, China.中国武汉眼科专业人员中的有症状新型冠状病毒肺炎
Ophthalmology. 2020 Sep;127(9):1268-1270. doi: 10.1016/j.ophtha.2020.04.026. Epub 2020 Apr 18.
9
Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic.新型冠状病毒肺炎(COVID-19)表现为结膜炎:大流行期间非典型高风险情况
Cont Lens Anterior Eye. 2020 Jun;43(3):211-212. doi: 10.1016/j.clae.2020.04.010. Epub 2020 Apr 27.
10
Sustainable practice of ophthalmology during COVID-19: challenges and solutions.COVID-19 期间眼科学的可持续实践:挑战与解决方案。
Graefes Arch Clin Exp Ophthalmol. 2020 Jul;258(7):1427-1436. doi: 10.1007/s00417-020-04682-z. Epub 2020 Apr 21.